Transplant Patients with Ebv Viremia At High Risk For Developing Recurrent Ebv Lymphoma
📧 Sign up to get email alerts when something new happens for Transplant Patients with Ebv Viremia At High Risk For Developing Recurrent Ebv Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies [Phase 2]
Phase 2 clinical trial evaluating Epstein-Barr Virus (EBV) immune T-lymphocytes from a normal HLA-compatible donor for EBV-related lymphopro…